DESIGN, OPTIMIZATION, DEVELOPMENT AND EVALUATION OF ONCE A DAY CONTROLLED RELEASE FORMULATION OF RIVASTIGMINE TARTARATE

  • Mohammed Abdul razack
  • G S Prasad Department of Pharmacy, Annamalai University, Annamalainagar 608002, Chidambaram, Tamil Nadu, India

Abstract

Rivastigmine, an Anti-Alzheimer’s drug suffer from a major limitation of sever GI adverse events such as nausea, vomiting, diarrhea, loss of appetite, weight loss and increase dosing frequency [1]. The present work aim at design, optimization and development of rivastigmine once a day controlled release formulation to minimize the above limitation and increase patient’s compliance. Based on the target in-vitro release profile derived from pharmacokinetic simulation [2], a once a day matrix tablet with the simulated dose was developed. The simple direct compression process was followed as a manufacturing process, the percentage of Polymer HPMC K100M, Polyethylene oxide (PEO WSR303) and insoluble excipients microcrystalline cellulose used in the formulation were optimized using 23 full factorial design. The formulations were then evaluated for the physical characteristics of blend, tablets, swelling index, percentage of erosion, drug release and release rate kinetic. The quadratic model was suggested, contour and 3D graphs were generated. The optimized formulation was subjected to stability studies. The final optimized formulation showed a comparative release profile similar to that the desired in-vitro target release profile, which followed zero order release kinetics and a stable formulation.

Keywords: Controlled Release Formulation, Rivastigmine Tartarate, Anti-Alzheimer’s drug, HPMC K100M, Polyethylene oxide (PEO WSR303)

Downloads

Download data is not yet available.

Author Biographies

Mohammed Abdul razack
G S Prasad, Department of Pharmacy, Annamalai University, Annamalainagar 608002, Chidambaram, Tamil Nadu, India
Department of Pharmacy, Annamalai University, Annamalainagar 608002, Chidambaram, Tamil Nadu, India
Statistics
161 Views | 278 Downloads
How to Cite
1.
Abdul razack M, Prasad G. DESIGN, OPTIMIZATION, DEVELOPMENT AND EVALUATION OF ONCE A DAY CONTROLLED RELEASE FORMULATION OF RIVASTIGMINE TARTARATE. JDDT [Internet]. 15Nov.2014 [cited 26Oct.2021];4(6):58-7. Available from: https://jddtonline.info/index.php/jddt/article/view/1010